BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10843715)

  • 1. A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats.
    Strachan AJ; Woodruff TM; Haaima G; Fairlie DP; Taylor SM
    J Immunol; 2000 Jun; 164(12):6560-5. PubMed ID: 10843715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.
    Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
    Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J
    J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.
    Finch AM; Wong AK; Paczkowski NJ; Wadi SK; Craik DJ; Fairlie DP; Taylor SM
    J Med Chem; 1999 Jun; 42(11):1965-74. PubMed ID: 10354404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat.
    Short A; Wong AK; Finch AM; Haaima G; Shiels IA; Fairlie DP; Taylor SM
    Br J Pharmacol; 1999 Feb; 126(3):551-4. PubMed ID: 10188960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59.
    Mizuno M; Nishikawa K; Morgan BP; Matsuo S
    Clin Exp Immunol; 2000 Feb; 119(2):368-75. PubMed ID: 10632677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal pharmacology of small molecule cyclic C5a antagonists.
    Proctor LM; Woodruff TM; Sharma P; Shiels IA; Taylor SM
    Adv Exp Med Biol; 2006; 586():329-45. PubMed ID: 16893082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist.
    Haynes DR; Harkin DG; Bignold LP; Hutchens MJ; Taylor SM; Fairlie DP
    Biochem Pharmacol; 2000 Sep; 60(5):729-33. PubMed ID: 10927032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of a membrane complement regulatory protein by a monoclonal antibody induces acute lethal shock in rats primed with lipopolysaccharide.
    Mizuno M; Nishikawa K; Okada N; Matsuo S; Ito K; Okada H
    J Immunol; 1999 May; 162(9):5477-82. PubMed ID: 10228027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide derived from the parasite receptor, complement C2 receptor inhibitor trispanning, suppresses immune complex-mediated inflammation in mice.
    Inal JM; Schneider B; Armanini M; Schifferli JA
    J Immunol; 2003 Apr; 170(8):4310-7. PubMed ID: 12682267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor.
    Höpken UE; Lu B; Gerard NP; Gerard C
    J Exp Med; 1997 Aug; 186(5):749-56. PubMed ID: 9271590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung.
    Baumann U; Chouchakova N; Gewecke B; Köhl J; Carroll MC; Schmidt RE; Gessner JE
    J Immunol; 2001 Jul; 167(2):1022-7. PubMed ID: 11441111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine.
    Arumugam TV; Shiels IA; Woodruff TM; Reid RC; Fairlie DP; Taylor SM
    J Surg Res; 2002 Apr; 103(2):260-7. PubMed ID: 11922743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
    March DR; Proctor LM; Stoermer MJ; Sbaglia R; Abbenante G; Reid RC; Woodruff TM; Wadi K; Paczkowski N; Tyndall JD; Taylor SM; Fairlie DP
    Mol Pharmacol; 2004 Apr; 65(4):868-79. PubMed ID: 15044616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of C5a receptor in mouse microvascular endothelial cells.
    Laudes IJ; Chu JC; Huber-Lang M; Guo RF; Riedemann NC; Sarma JV; Mahdi F; Murphy HS; Speyer C; Lu KT; Lambris JD; Zetoune FS; Ward PA
    J Immunol; 2002 Nov; 169(10):5962-70. PubMed ID: 12421982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes.
    Woodruff TM; Strachan AJ; Sanderson SD; Monk PN; Wong AK; Fairlie DP; Taylor SM
    Inflammation; 2001 Jun; 25(3):171-7. PubMed ID: 11403208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats.
    Proctor LM; Strachan AJ; Woodruff TM; Mahadevan IB; Williams HM; Shiels IA; Taylor SM
    Int Immunopharmacol; 2006 Aug; 6(8):1224-32. PubMed ID: 16782534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo.
    Pellas TC; Boyar W; van Oostrum J; Wasvary J; Fryer LR; Pastor G; Sills M; Braunwalder A; Yarwood DR; Kramer R; Kimble E; Hadala J; Haston W; Moreira-Ludewig R; Uziel-Fusi S; Peters P; Bill K; Wennogle LP
    J Immunol; 1998 Jun; 160(11):5616-21. PubMed ID: 9605167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat.
    Woodruff TM; Strachan AJ; Dryburgh N; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    Arthritis Rheum; 2002 Sep; 46(9):2476-85. PubMed ID: 12355496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.